BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2019
View Archived Issues
Psychiatric risk genes can have distinct effects in different disorders
Read More
Mouse model devised to understand the potential of autophagy enhancers in treating ALS
Read More
FDA approves IND for phase I trial of TransThera's TT-00920 for heart failure
Read More
Hyper-sialylated IgG product M-254 well tolerated in healthy subjects in first-in-human trial
Read More
Topline data reported from phase II study of ARQ-151 in atopic dermatitis
Read More
Alnylam presents topline data from ILLUMINATE-A phase III study of lumasiran
Read More
Cerevance and Takeda collaborate to advance novel therapies for gastrointestinal disorders
Read More
KIN-8194 overcomes BTK C481S-mediated ibrutinib resistance in preclinical models
Read More
Peloton Therapeutics discloses new 5'-nucleotidase inhibitors
Read More
D-amino-acid oxidase inhibitors discovered at SyneuRx International
Read More
Roche patents bacterial DNA gyrase and/or DNA topoisomerase IV inhibitors
Read More
FronThera US Pharmaceuticals presents ENPP2 inhibitors
Read More
New analgesics identified at CerSci Therapeutics
Read More
Phase I results of intratumoral administration of tigilanol tiglate support further development
Read More
Pilot clinical results for ondansetron in patients with bipolar disorder and alcohol dependence
Read More
First-in-class RSK inhibitor PMD-026 shows promise for triple-negative breast cancer
Read More
New human autoinflammatory disease discovered
Read More
Adamas reports results of phase III study of ADS-5102 in MS with walking impairment
Read More
INB-03 phase I data support progression to phase II in breast cancer
Read More
Homology reports initial data from phase I/II study of HMI-102 gene therapy in PKU
Read More
DiaMedica initiates phase II study of DM-199 in chronic kidney disease
Read More
ARM-210 studied in new clinical trial for ryanodine receptor type 1-related myopathies
Read More
Phase Ib data on PXL-065 support progression to phase II for NASH
Read More
Nordic Nanovector receives funding to support Alpha37 program
Read More
BioInvent and MSD enter clinical trial collaboration to study BI-1206 with Keytruda in solid tumors
Read More
Proteostasis reports phase II topline data on CFTR modulator combinations in cystic fibrosis
Read More